These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9152779)

  • 21. [The viral and immunological characteristics of cardiomyopathies and myocarditis].
    Moiseev VS; Ogurtsov PP; Traianova TG; Savinov AP; Lavrova IK; Stepina VN; Shelepin AA; Rukosuev VS; Tereshchenko SE; Korovina EA
    Ter Arkh; 1990; 62(8):77-82. PubMed ID: 2274878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viruses in the Heart: Direct and Indirect Routes to Myocarditis and Heart Failure.
    Martens CR; Accornero F
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-dimensional electrophoresis of heart muscle proteins in human cardiomyopathies.
    Kovalyov LI; Naumov VG; Pulyayeva HV; Samko AM; Tsvetkova MN; Shishkin SS; Mukharlyamov NM
    Electrophoresis; 1990 Apr; 11(4):333-6. PubMed ID: 2340830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low prevalence of hepatitis C virus antibodies and RNA in patients with myocarditis and dilated cardiomyopathy.
    Grumbach IM; Heermann K; Figulla HR
    Cardiology; 1998 Oct; 90(2):75-8. PubMed ID: 9778541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral causes of cardiac inflammation.
    Bowles NE; Vallejo J
    Curr Opin Cardiol; 2003 May; 18(3):182-8. PubMed ID: 12826818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory Cardiomyopathic Syndromes.
    Trachtenberg BH; Hare JM
    Circ Res; 2017 Sep; 121(7):803-818. PubMed ID: 28912184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
    Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
    Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dilated cardiomyopathy--new insights into the pathogenesis.
    Why HJ; Archard LC; Richardson PJ
    Postgrad Med J; 1994; 70 Suppl 1():S2-7. PubMed ID: 7971644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus and cardiomyopathy.
    Matsumori A
    Herz; 2000 May; 25(3):249-54. PubMed ID: 10904847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiomyopathy: molecular and immunological aspects (review).
    Takeda N
    Int J Mol Med; 2003 Jan; 11(1):13-6. PubMed ID: 12469210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection.
    Yajima T
    Future Microbiol; 2011 May; 6(5):551-66. PubMed ID: 21585262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate signaling promotes formation of regulatory nitric oxide-producing dendritic cells limiting T-cell expansion in experimental autoimmune myocarditis.
    Kania G; Siegert S; Behnke S; Prados-Rosales R; Casadevall A; Lüscher TF; Luther SA; Kopf M; Eriksson U; Blyszczuk P
    Circulation; 2013 Jun; 127(23):2285-94. PubMed ID: 23671208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated nuclear transcription factor kappaB in patients with myocarditis and dilated cardiomyopathy--relation to inflammation and cardiac function.
    Alter P; Rupp H; Maisch B
    Biochem Biophys Res Commun; 2006 Jan; 339(1):180-7. PubMed ID: 16297880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autophagy, Myocarditis, and Cardiomyopathy.
    Du J; Liu Y; Fu J
    Adv Exp Med Biol; 2020; 1207():229-235. PubMed ID: 32671752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral Infection of the Heart: Pathogenesis and Diagnosis.
    Kuffner M; Pawlak A; Przybylski M
    Pol J Microbiol; 2017 Jan; 65(4):391-398. PubMed ID: 28735322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation in dilated cardiomyopathy.
    Pankuweit S; Ruppert V; Maisch B
    Herz; 2004 Dec; 29(8):788-93. PubMed ID: 15599676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium channel blocker-induced protection against cardiovascular damage.
    Matsumori A
    Int J Cardiol; 1997 Dec; 62 Suppl 2():S39-46. PubMed ID: 9488194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The expression of coxsackie B virus adenovirus receptor (CAR) in viral myocarditis and dilated cardiomyopathy patients].
    Li HY; Li YH; Zhu TJ
    Fa Yi Xue Za Zhi; 2007 Aug; 23(4):247-9. PubMed ID: 17896511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity.
    Maekawa Y; Ouzounian M; Opavsky MA; Liu PP
    Circulation; 2007 Jan; 115(1):5-8. PubMed ID: 17200452
    [No Abstract]   [Full Text] [Related]  

  • 40. Myocarditis and heart failure associated with hepatitis C virus infection.
    Matsumori A; Shimada T; Chapman NM; Tracy SM; Mason JW
    J Card Fail; 2006 May; 12(4):293-8. PubMed ID: 16679263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.